Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ CD66e/CD3 (Cibisatamab Biosimilar) Recombinant Human Monoclonal Antibody
GREENER_CHOICE

Catalog No. PIMA542186
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA542186 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. PIMA542186 Supplier Invitrogen™ Supplier No. MA542186
Add to Cart
Add to Cart
This item is not returnable. View return policy

Human Recombinant Monoclonal Antibody

Endotoxin level <0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt. This product is a Humanized mouse antibody.

CEA (Carcinoembryonic Antigen, CD66e) is a glycoprotein normally produced during fetal development in the gastrointestinal tract and re-expressed at high levels in many cancers, particularly colorectal and other adenocarcinomas. It belongs to the immunoglobulin superfamily and contains one variable-like N domain and six constant-like domains (A1-A3, B1-B3). CEA is widely used as a tumor marker, especially for adenocarcinomas of the digestive tract. It is helpful in identifying the origin of metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinoma (often CEA-positive) from pleural mesothelioma (rarely CEA-positive). The CEA gene family, including CEA cell adhesion molecules and pregnancy-specific glycoproteins, is clustered on chromosome 19 and includes several pseudogenes. Originally identified as a biliary glycoprotein, CEA is now recognized as a cell adhesion molecule expressed on epithelial, endothelial, and some immune cells. It mediates homophilic and heterophilic cell adhesion and has been implicated in tissue organization, angiogenesis, apoptosis, metastasis, tumor progression, and modulation of immune responses. Multiple transcript variants exist, though not all are fully characterized.CD3 is a multi-subunit complex (gamma, delta, epsilon, and zeta) essential for assembly and surface expression of the T cell receptor (TCR). These immunoglobulin superfamily proteins are encoded by closely linked genes on chromosome 11 and are expressed on thymocytes and all mature T cells, but not on B or NK cells. CD3 transduces antigen-recognition signals into T cells through tyrosine-based motifs in its cytoplasmic tails. TCR engagement activates signaling pathways that drive T cell activation, proliferation, survival, or growth arrest. CD3 defects cause immunodeficiency, underscoring its critical role in immune regulation.
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD66e/CD3 (Cibisatamab Biosimilar)
Applications ELISA, SDS-Page
Classification Recombinant Monoclonal
Concentration 2.54 mg/mL
Conjugate Unconjugated
Formulation PBS with no preservative; pH 7.4
Gene Alias CEA TCB; RG-7802; RO-6958688
Host Species Human
Immunogen Human CD3E/CEACAM5.
Purification Method Protein A/G
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1 κ, IgG1 λ
Target Molecule Chemical
Show More Show Less
WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.